ஆண்டு சேர்க்கப்பட்டுள்ளது நீண்டது கால ஓவரால் பிழைப்பு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Sierra Oncology Reports 2020 Year End Results
News provided by
Share this article
Share this article
– MOMENTUM Phase 3 Trial on Track to Complete Enrollment in mid-2021 with Top-line Data Anticipated in H1 2022 –
– Data Presented Throughout the Year Included Long-Term Overall Survival, Efficacy in Various
Patient Subsets and Dosing Durability –
– Key Appointments Made to Executive Team in Preparation for Commercial Execution –
SAN MATEO, Calif., March 11, 2021 /PRNewswire/ - Sierra Oncology, Inc. (SRRA), a late-stage biopharmaceutical company on a quest to deliver targeted therapies that treat rare forms of cancer, today reported its financial and operational results for the fourth quarter and fiscal year ended December 31, 2020. ....

United States , William Turner , Christina Thomson , Kevin Norrett , Exchange Commission , American Society Of Hematology , Sierra Oncology Inc , European Hematology Association , Pioneer Fund , Gilead Sciences Inc , Complete Enrollment , Top Line Data Anticipated , Data Presented Throughout , Year Included Long Term Overall Survival , Dosing Durability , Key Appointments Made , Executive Team , Commercial Execution , Stephen Dilly , American Society , Upcoming Business , Chief Executive Officer , Chief Business Officer , General Counsel , Chief Regulatory , Technical Operations Officer ,